ActivOzone PREMIUM60 Supplement

The first microencapsulated Ozone dietary supplement in the world …

This product is designed for all persons wishing to initiate or complement a therapy with ozone and to enhance other therapeutics with or without ozone.

PREMIUM60 avoids the anticipated release of ozone given its molecular microencapsulation.

The main advantages of this product are the controlled release of ozone in the body through molecular microencapsulation and the systemic introduction of ozone in low concentrations.

  Ask a Question
Chef

Description

Benefits of Ozone Therapy

  • Dramatically increase oxygenation of the tissues and cells
  • Stimulate the Immune System
  • Increase the White Blood Cell count
  • Increase circulation, oxygen and nutrient delivery within the body
  • Increase the distensibility of the Red Blood Cell so that it can squeeze through your tiny blood vessels into tissues
  • Boost cellular mediated immunity (part of the immune system)
  • Increase 2,3-DPG: Responsible for the blood’s ability to release oxygen in your tissues
  • Increase tumor necrosis factor by up to 500 times
  • Purge the body of accumulated toxins such as pesticides, PCBs, drug residues, and acidic wastes
  • Produce Interleukin II, Gamma interferon (anti-cancer substances)


Like the other methods of ozone delivery, ActivOzone offers positive results. Conditions that may benefit from treatment with Ozone Therapy include:

Cancer

Meniscal tears and joint disorders

Shingles (Herpes zoster) and Herpes Simplex

Herniated Discs

Diabetic ulcers and venous stasis

Allergies & chronic sinusitis

Lyme disease

Alzheimer’s, senile dementia

Arthritis

Autoimmune diseases

Colitis and Crohn’s

Tinnitus

Vaginal infections

Chronic hepatitis

Chronic Fatigue Syndrome

Fibromyalgia

Candidiasis and many more conditions

Reviews

There are no reviews yet.

Be the first to review “ActivOzone PREMIUM60 Supplement”

Your email address will not be published.

No more offers for this product!

General Inquiries

There are no inquiries yet.